Horter SCB, Stringer B, Greig J, Amangeldiev A, Tillashaikhov M, et al.
2016-07-28 • BMC Infectious Diseases
2016-07-28 • BMC Infectious Diseases
BACKGROUND Treatment for multi-drug resistant tuberculosis (MDR-TB) is lengthy, has severe side effects, and raises adherence challenges. In the Médecins Sans Frontières (MSF) and Mi...
du Cros PAK, Khamraev AK, Tigay Z, Abdrasuliev T, Greig J, et al.
2021-02-08 • ERJ open research
2021-02-08 • ERJ open research
BACKGROUND In 2016, World Health Organization guidelines conditionally recommended standardised shorter 9–12-month regimens for multidrug-resistant (MDR) tuberculosis (TB) treatment....